Skip to content
< Back to blog

Devyser signs agreement with Veritas Corporation


News | February 10, 2023

We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for the Japanese market. Veritas is a trading company specializing in biotechnology with a long history and deep understanding of the Japanese biotechnology market.  They will be an acknowledged partner for all Devyser products.  

Veritas will start to introduce Devyser NGS tests to Japanese customers. Mr. Yuya Yukozawa, Manager at the Bioscience Department at Veritas, is of the opinion that the simplicity of Devysers NGS workflow will be appealing to the Japanese market which today uses other more complicated and time-consuming methods.  

“The Devyser NGS kits have proven to be easy to use and require very little hands-on time for lab personnel and this will be important for Japanese users of these kits, says Mr. Yukozawa”. 

Introducing new technologies is generally demanding in Japan but the strong scientific and technical knowledge of Vertitas sales, marketing, and technical support staff will allow us to enter the promising Japanese market. 

“Vertitas network will provide us with the market penetration needed to reach full sales potential. We are confident that Veritas will help us leverage our position in the Japanese market, says Theis Kipling, Chief Commercial Officer at Devyser.” 

We, at Devyser, are once again pioneering in a new market to strive for a world where personalized medicine is universally available thanks to simplified and reliable genetic tests. 

Visit their website

Contact an expert at Devyser

If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.

Contact us